Subscribe to Newsletter

George Vasmatzis and John Cheville

George Vasmatzis and John Cheville are co-directors of the Biomarker Discovery Program within the Center for Individualized Medicine, Mayo Clinic, US.

Content by George Vasmatzis and John Cheville:

 Diagnostics Biochemistry and molecular biology

Treat or Surveil

| George Vasmatzis and John Cheville

Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register

October Issue of The Pathologist